Skip to content
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Search
Login
About Us
News
Webinars & Events
Resources
Contact Us
About Us
News
Webinars & Events
Resources
Contact Us
Tag: OPDP enforcement
12/20/2019
Press Release Highlighting Omission of Risk Warning Letter Closes OPDP’s Enforcement Year
Learn More
12/01/2019
Promotion of IND for Brain Cancer Treatment Prompts OPDP Enforcement Letter
Learn More
09/09/2019
OPDP Warning Letter: Omission of Risk Info in DTC Print Ad/Display Banners Misbrands ED Drug
Learn More
08/05/2019
Latest OPDP Enforcement Letters: Don’t Omit or Distract from Risk Information
Learn More
06/19/2019
OPDP Untitled Letter Cites False, Misleading Claims about Efficacy, Risk Presentation for Obesity Drug
Learn More
04/30/2019
OPDP Issues Enforcement Letter for Investigational Drug Promotion
Learn More
11/02/2018
OPDP Cites Lack of Risk Information in Second Warning Letter of 2018
Learn More
10/19/2018
Bad Ad Program Yields Two OPDP Enforcement Letters on Risk, Safety Information
Learn More
«
Page
1
Page
2
»
